Teleflex Incorporated (TBH.F)
| Previous close | 195.00 |
| Open | 194.00 |
| Bid | 194.00 x 10000 |
| Ask | 199.00 x 10000 |
| Day's range | 194.00 - 194.00 |
| 52-week range | 167.00 - 234.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 9.191B |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | 33.62 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.25 (0.64%) |
| Ex-dividend date | 14 May 2024 |
| 1y target est | N/A |
- GlobeNewswire
Teleflex Publishes 2023 Global Impact Report
Highlights Accomplishments and Sets Goals for Corporate Social Responsibility ProgramWAYNE, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has published its 2023 Global Impact Report. The report outlines recent accomplishments and sets new targets to support the company’s Corporate Social Responsibility (CSR) program and aligns with the Global Reporting Initiative (GRI), the Sustainability Accounting
- GlobeNewswire
Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow™ EZ-IO™ Intraosseous Access Procedure Tray
The First and Only Sterile, Single-Use IO Tray Cleared by the U.S. Food and Drug AdministrationWAYNE, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies and pioneer in intraosseous vascular access, today announced the launch of the Arrow™ EZ-IO™ Intraosseous Access Procedure Tray. This sterile, single-use tray includes all the components required for the IO access procedure, enabling a streamlined clinician workflow. The new Arrow™ EZ
- GlobeNewswire
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American Urological Association Annual Meeting in San Antonio, TX, May 3 – 6, 2024, showcasing excellent patient experience* with the Prostatic Urethral Lift (PUL) with the UroLift™ System for benign prostatic hyperplasia (BPH). This year’s research marks the first time results from two randomized head-to-
